Critical Care

official impact factor 4.60

Open Access Highly Access Email this article to a friend

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials

Sandro B Rizoli*, Kenneth D Boffard, Bruno Riou, Brian Warren, Philip Iau, Yoram Kluger, Rolf Rossaint, Michael Tillinger and the NovoSeven® Trauma Study Group

Critical Care 2006, 10:R178 doi:10.1186/cc5133

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.